These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20020057)

  • 1. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
    Hashem AM; Flaman AS; Farnsworth A; Brown EG; Van Domselaar G; He R; Li X
    PLoS One; 2009 Dec; 4(12):e8350. PubMed ID: 20020057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurintricarboxylic acid inhibits influenza virus neuraminidase.
    Hung HC; Tseng CP; Yang JM; Ju YW; Tseng SN; Chen YF; Chao YS; Hsieh HP; Shih SR; Hsu JT
    Antiviral Res; 2009 Feb; 81(2):123-31. PubMed ID: 19014974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Kati WM; Montgomery D; Carrick R; Gubareva L; Maring C; McDaniel K; Steffy K; Molla A; Hayden F; Kempf D; Kohlbrenner W
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1014-21. PubMed ID: 11897583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
    Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
    Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
    Pontoriero A; Baumeister E; Campos AM; Savy VL
    Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punicalagin is a neuraminidase inhibitor of influenza viruses.
    Li P; Du R; Chen Z; Wang Y; Zhan P; Liu X; Kang D; Chen Z; Zhao X; Wang L; Rong L; Cui Q
    J Med Virol; 2021 Jun; 93(6):3465-3472. PubMed ID: 32827314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of oseltamivir phosphonate congeners as anti-influenza agents.
    Cheng TJ; Weinheimer S; Tarbet EB; Jan JT; Cheng YS; Shie JJ; Chen CL; Chen CA; Hsieh WC; Huang PW; Lin WH; Wang SY; Fang JM; Hu OY; Wong CH
    J Med Chem; 2012 Oct; 55(20):8657-70. PubMed ID: 23009169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
    Zhao X; Li R; Zhou Y; Xiao M; Ma C; Yang Z; Zeng S; Du Q; Yang C; Jiang H; Hu Y; Wang K; Mok CKP; Sun P; Dong J; Cui W; Wang J; Tu Y; Yang Z; Hu W
    J Med Chem; 2018 Jun; 61(12):5187-5198. PubMed ID: 29799746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.
    Yamada H; Nagase S; Takahashi K; Sakoda Y; Kida H; Okamoto S
    Antiviral Res; 2016 May; 129():81-92. PubMed ID: 26923882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
    Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
    Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
    Dao TT; Dang TT; Nguyen PH; Kim E; Thuong PT; Oh WK
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3688-92. PubMed ID: 22552195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
    Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
    Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
    Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.